Recent Updates
Recently added Catalysts
DRIO Positive Sentiment Score: 65/100

DARIOHEALTH TO REPORT FOURTH QUARTER 2023 RESULTS ON THURSDAY, MARCH 28TH

Key Takeaway: DarioHealth Corp. (Nasdaq: DRIO) has announced the forthcoming release of its financial results for the fourth quarter ending December 31, 2023. The financial disclosures are scheduled for March 28, 2024, before market opening, followed by a conference call at 8:30 am ET. The company continues to highlight its leading position in the digital therapeutics market, focusing on personalized care for chronic health conditions.

Market Sentiment Analysis

POSITIVE FACTORS

  • Announces anticipated financial results for Q4 2023.
  • Provides an outline for a conference call, enhancing transparency.
  • Emphasis on user-centric approach in digital therapeutics.

Full Press Release Details

Company to host conference call and webcast at 8:30am ET
NEW YORK, March 21, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it will release its financial results for the 4th quarter ended December 31, 2023, on Thursday, March 28th, 2024, before the market opens and will host a conference call and webcast at 8:30 am Eastern Time.
Erez Raphael, Chief Executive Officer and Rick Anderson, President, will host the call.
Conference Call Details
Date: Thursday, March 28th, 8:30am ET
Dial-in Number: 1-888-886-7786 (domestic) or 1-416-764-8658 (international)
Participants can use the dial-in numbers above and be answered by an operator OR click the Call me™ link for instant telephone access to the event. This link will be made active 15 minutes prior to scheduled start time.
Participants are asked to dial in approximately 10 minutes prior to the start of the event. A replay of the call will be available approximately two hours after completion through Sunday, April 28th, 2024. To listen to the replay, dial 1-844-512-2921 (domestic) or 1-412-317-6671 (international) and use replay passcode 63790103.
About DarioHealth Corp.
DarioHealth Corp. (Nasdaq: DRIO) is a leading digital therapeutics (DTx) company revolutionizing how people with chronic conditions manage their health through a user-centric multi-chronic condition platform. Our platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Our user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention, and results. Making the right thing to do the easy thing to do.
Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers. To learn more about DarioHealth and its digital health solutions, or for more information, visit http://dariohealth.com.
DarioHealth Corporate Contact
DarioHealth Investor Relations Contact
Investor Relations Manager
SOURCE DarioHealth Corp.

21 %

more press release views with

Frequently Asked Questions

When will DarioHealth release its financial results?

DarioHealth will announce its financial results on March 28, 2024.

What time is the DarioHealth conference call scheduled?

The conference call is set for 8:30 am ET on March 28, 2024.

How can I access the DarioHealth conference call?

Participants can dial in or click the provided Call me™ link for access.

Is there a replay available for the conference call?

Yes, a replay will be available approximately two hours after the call.

What services does DarioHealth provide?

DarioHealth offers a platform for managing chronic conditions through digital therapeutics.

Last updated: Mar 21, 2024